Published in Lab Business Week, January 1st, 2006
Researchers in the United States report, "It has been known for 50 years that transaminase activity increases in patients with acute myocardial infarction. With the development of creatine kinase (CK), biomarkers of cardiac injury began to take a major role in the diagnosis and management of patients with acute cardiovascular disease."
L. Babuin and colleagues at the Mayo Clinic wrote, "In 2000, the European Society of Cardiology and the American College of Cardiology recognized the pivotal role of biomarkers and made elevations in their levels the 'cornerstone' of diagnosis of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week